Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
RA Capital Management, L.P. | 0 0.000% |
-388,385 (Position Closed) |
Filing History |
| 2022-02-14 4:05 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
D. E. SHAW & CO L.P. | 764,613 3.500% |
44,240 (+6.14%) |
Filing History |
| 2022-02-14 3:04 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Cormorant Asset Management LP | 1,436,322 6.280% |
1,436,322 (New Position) |
Filing History |
| 2022-02-14 2:47 pm Sale |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Logos Global Management LP | 0 0.000% |
-1,495,000 (Position Closed) |
Filing History |
| 2022-02-14 1:51 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BIOTECHNOLOGY VALUE FUND L P | 2,202,315 9.990% |
2,202,315 (New Position) |
Filing History |
| 2022-02-14 06:19 am Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Citadel Advisors LLC | 943,340 4.300% |
943,340 (New Position) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 1,209,051 5.570% |
1,209,051 (New Position) |
Filing History |
| 2022-02-11 4:19 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Ally Bridge MedAlpha Master Fund L.P. | 604,774 2.800% |
604,774 (New Position) |
Filing History |
| 2022-02-04 08:01 am Sale |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Hawkes Bay Master Investors (Cayman) L.P. | 0 0.000% |
-363,284 (Position Closed) |
Filing History |
| 2022-01-28 1:39 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 1,505,200 6.900% |
200,000 (+15.32%) |
Filing History |
| 2021-10-27 6:12 pm Purchase |
2021-10-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Avidity Partners Management LP | 1,120,925 6.600% |
1,120,925 (New Position) |
Filing History |
| 2021-10-14 4:05 pm Purchase |
2021-10-04 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 1,943,055 9.990% |
1,943,055 (New Position) |
Filing History |
| 2021-10-08 08:36 am Sale |
2021-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Wellington Management Group LLP | 0 0.000% |
-578,560 (Position Closed) |
Filing History |
| 2021-09-30 4:30 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Vivo Opportunity LLC | 1,300,000 7.700% |
1,300,000 (New Position) |
Filing History |
| 2021-09-29 09:30 am Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Logos Global Management LP | 1,495,000 8.800% |
1,495,000 (New Position) |
Filing History |
| 2021-09-29 06:02 am Unchanged |
2021-09-23 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 8.200% |
0 (Unchanged) |
Filing History |
| 2021-09-24 5:01 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 1,819,689 9.900% |
1,819,689 (New Position) |
Filing History |
| 2021-09-24 1:59 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 13.700% |
400,000 (+43.76%) |
Filing History |
| 2021-09-23 4:31 pm Purchase |
2021-09-21 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 3,460,351 19.990% |
3,460,351 (New Position) |
Filing History |
| 2021-09-10 06:03 am Purchase |
2021-09-01 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 914,000 9.500% |
914,000 (New Position) |
Filing History |